Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Blood-Based Viral Signature Identified in Crohn’s Disease

By LabMedica International staff writers
Posted on 02 Mar 2026

Crohn’s disease is a chronic inflammatory intestinal disorder affecting approximately 0. More...

4% of the European population, with symptoms and progression that vary widely. Although viral components of the microbiome are drawing increasing attention, the gut virome is highly diverse, and individuals rarely share the same species profile, complicating comparisons. Given the increased intestinal permeability associated with Crohn’s disease, researchers suspected that viral composition in the blood might also be altered. They now report a distinctive blood-based viral signature linked to the disease.

Scientists at the French National Research Institute for Agriculture, Food and Environment (INRA), together with Sorbonne University and AP‑HP Saint Antoine, identified a viral blood signature centered on bacteriophages—viruses that infect bacteria. Investigators compared the blood virome between patients and healthy subjects and found reproducible differences in phage profiles associated with Crohn’s disease. The work establishes the presence of a low-abundance circulating virome in all individuals and indicates that its composition varies with disease status.

In a comparative study, blood from 15 patients with Crohn’s disease was analyzed alongside samples from 14 healthy controls. Low concentrations of viral particles were detected in both groups, averaging about 100,000 particles per milliliter of blood, versus an estimated one billion particles per gram in the gut virome. Bacteriophages predominated across participants, with roughly 150 phage species per individual, and only a small minority of human viruses detected, identified as nonpathogenic anelloviruses.

Distinct compositional differences emerged between groups. Bacteriophages that target bacteria of the genus Acinetobacter were observed in controls but were almost absent in samples from individuals with Crohn’s disease. Conversely, a wide variety of bacteriophages that target typical hosts, including intestinal bacteria, appeared only in the Crohn’s disease group. These findings both confirm a blood virome in all individuals and enable detection of a signature for Crohn’s disease. The findings were detailed in a study published in Gastroenterology.

The authors note that the data open new research directions, including investigation of bacteriophage translocation linked to gut barrier dysfunction, analysis of larger validation cohorts or more homogeneous disease subgroups, and exploration of how viruses persist in the blood despite an operational immune system. The team also highlights the possibility that reduced intestinal barrier function in Crohn’s disease could underlie the observed blood virome shifts.

Related Links:
INRAE 


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Platinum Member
Integrated Biochemical & Immunological System
Biolumi CX Solution X10+C10
Gold Member
Aspiration System
VACUSAFE
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image Credit: Adobe Stock

AI in Cancer Diagnosis and Molecular Testing Takes Center Stage at AMP 2026

Artificial intelligence (AI) is increasingly being integrated into molecular diagnostics, offering new approaches to interpreting complex genetic information, classifying cancers, and optimizing laboratory testing.... Read more

Immunology

view channel
Image: The panel expands Cepheid’s respiratory testing portfolio on the GeneXpert platform, offering laboratories greater flexibility in selecting tests based on clinical needs. (Photo courtesy of Cepheid)

Multiplex PCR Test Gains CE Marking to Support Respiratory Infection Diagnosis

Acute respiratory infections often present with overlapping symptoms, making it difficult to distinguish between viral and bacterial causes. Seasonal surges of influenza-like illness in Europe further... Read more

Pathology

view channel
Image Credit: Adobe Stock

New Training Approach Helps AI Distinguish Neighboring Cells in Tissue

Artificial intelligence (AI) can assist with identifying cells in digital pathology images, but densely packed tissue remains difficult to analyze. Neighboring cells may be merged, counted twice, or missed,... Read more

Industry

view channel
Image: The TOMR trial uses Signatera-guided MRD testing to identify high-risk patients for curative-intent treatment.

Natera and Incyte Collaborate on MRD-Guided Colorectal Cancer Treatment Study

Natera (Austin, TX, USA) has entered into a clinical collaboration with Incyte (Wilmington, DE, USA) for a Phase II study evaluating molecular residual disease (MRD)-guided treatment in colorectal cancer.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.